testosterone enanthate has been researched along with HIV Coinfection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rubin, D; Segal-Maurer, S; Wasserman, P | 1 |
| Bhasin, S; Dzekov, C; Dzekov, J; Herbst, KL; Knapp, PE; LaValley, M; Singh, AB; Storer, TW; Ulloor, J; Zhang, A | 1 |
1 trial(s) available for testosterone enanthate and HIV Coinfection
| Article | Year |
|---|---|
Effects of a supraphysiological dose of testosterone on physical function, muscle performance, mood, and fatigue in men with HIV-associated weight loss.
Topics: Absorptiometry, Photon; Adolescent; Adult; Affect; Body Composition; Double-Blind Method; Fatigue; HIV; HIV Infections; Humans; Male; Middle Aged; Muscle Strength; Quality of Life; Statistics, Nonparametric; Surveys and Questionnaires; Testosterone; Walking; Weight Loss | 2008 |
1 other study(ies) available for testosterone enanthate and HIV Coinfection
| Article | Year |
|---|---|
Low sex hormone-binding globulin and testosterone levels in association with erectile dysfunction among human immunodeficiency virus-infected men receiving testosterone and oxandrolone.
Topics: Adult; Androgens; Antiretroviral Therapy, Highly Active; Drug Therapy, Combination; Erectile Dysfunction; HIV Infections; Humans; Hypogonadism; Male; Middle Aged; Oxandrolone; Sex Hormone-Binding Globulin; Testosterone; Treatment Outcome | 2008 |